ASPIRA WOMEN'S HEALTH INC (AWH) Fundamental Analysis & Valuation
NASDAQ:AWH • US04537Y2081
Current stock price
0.082 USD
-0.01 (-12.49%)
At close:
0.0395 USD
-0.04 (-51.83%)
After Hours:
This AWH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AWH Profitability Analysis
1.1 Basic Checks
- AWH had negative earnings in the past year.
- In the past year AWH has reported a negative cash flow from operations.
- In the past 5 years AWH always reported negative net income.
- In the past 5 years AWH always reported negative operating cash flow.
1.2 Ratios
- With a Return On Assets value of -238.46%, AWH is not doing good in the industry: 94.24% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -238.46% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AWH has a Gross Margin (59.67%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of AWH has grown nicely.
- AWH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
2. AWH Health Analysis
2.1 Basic Checks
- AWH does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AWH has more shares outstanding than it did 1 year ago.
- AWH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AWH has a worse debt to assets ratio.
2.2 Solvency
- AWH has an Altman-Z score of -143.66. This is a bad value and indicates that AWH is not financially healthy and even has some risk of bankruptcy.
- AWH has a worse Altman-Z score (-143.66) than 96.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -143.66 |
ROIC/WACCN/A
WACC7.54%
2.3 Liquidity
- A Current Ratio of 0.76 indicates that AWH may have some problems paying its short term obligations.
- AWH has a Current ratio of 0.76. This is amonst the worse of the industry: AWH underperforms 91.62% of its industry peers.
- AWH has a Quick Ratio of 0.76. This is a bad value and indicates that AWH is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.71, AWH is not doing good in the industry: 87.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.71 |
3. AWH Growth Analysis
3.1 Past
- AWH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.50%, which is quite impressive.
- The Revenue has been growing slightly by 0.24% in the past year.
- Measured over the past years, AWH shows a quite strong growth in Revenue. The Revenue has been growing by 15.13% on average per year.
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%
3.2 Future
- AWH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.55% yearly.
- The Revenue is expected to grow by 64.54% on average over the next years. This is a very strong growth
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. AWH Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for AWH. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AWH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as AWH's earnings are expected to grow with 32.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.55%
EPS Next 3YN/A
5. AWH Dividend Analysis
5.1 Amount
- No dividends for AWH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AWH Fundamentals: All Metrics, Ratios and Statistics
0.082
-0.01 (-12.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-13 2025-05-13/bmo
Inst Owners10.64%
Inst Owner Change-99.9%
Ins Owners13.72%
Ins Owner Change0%
Market Cap2.89M
Revenue(TTM)9.18M
Net Income(TTM)-13.09M
Analysts80
Price Target5.61 (6741.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.81%
Min Revenue beat(2)-19.22%
Max Revenue beat(2)-18.41%
Revenue beat(4)0
Avg Revenue beat(4)-15.56%
Min Revenue beat(4)-19.22%
Max Revenue beat(4)-7.73%
Revenue beat(8)0
Avg Revenue beat(8)-15.76%
Revenue beat(12)0
Avg Revenue beat(12)-13.9%
Revenue beat(16)3
Avg Revenue beat(16)-9.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.31 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.26
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -238.46% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.67% | ||
| FCFM | N/A |
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
F-Score4
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 40.22% | ||
| Cap/Sales | 0.4% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | -143.66 |
F-Score4
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)46.91%
Cap/Depr(5y)76.44%
Cap/Sales(3y)1.16%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%
EBIT growth 1Y13.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.79%
OCF growth 3YN/A
OCF growth 5YN/A
ASPIRA WOMEN'S HEALTH INC / AWH Fundamental Analysis FAQ
What is the fundamental rating for AWH stock?
ChartMill assigns a fundamental rating of 2 / 10 to AWH.
What is the valuation status of ASPIRA WOMEN'S HEALTH INC (AWH) stock?
ChartMill assigns a valuation rating of 1 / 10 to ASPIRA WOMEN'S HEALTH INC (AWH). This can be considered as Overvalued.
What is the profitability of AWH stock?
ASPIRA WOMEN'S HEALTH INC (AWH) has a profitability rating of 1 / 10.
What is the expected EPS growth for ASPIRA WOMEN'S HEALTH INC (AWH) stock?
The Earnings per Share (EPS) of ASPIRA WOMEN'S HEALTH INC (AWH) is expected to grow by 46.73% in the next year.